Works by Fukui, H.

Results: 80
    1
    2

    Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.

    Published in:
    Journal of Viral Hepatitis, 2010, v. 17, n. 5, p. 336, doi. 10.1111/j.1365-2893.2009.01182.x
    By:
    • Inoue, Y.;
    • Hiramatsu, N.;
    • Oze, T.;
    • Yakushijin, T.;
    • Mochizuki, K.;
    • Hagiwara, H.;
    • Oshita, M.;
    • Mita, E.;
    • Fukui, H.;
    • Inada, M.;
    • Tamura, S.;
    • Yoshihara, H.;
    • Hayashi, E.;
    • Inoue, A.;
    • Imai, Y.;
    • Kato, M.;
    • Miyagi, T.;
    • Hohsui, A.;
    • Ishida, H.;
    • Kiso, S.
    Publication type:
    Article
    3
    4

    Japan's Takeshita at the helm.

    Published in:
    Current History, 1988, v. 87, n. 528, p. 173, doi. 10.1525/curh.1988.87.528.173
    By:
    • Fukui, H.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Disappearance of serum HCV-RNA after short-term prednisolone therapy in a patient with chronic hepatitis C associated with autoimmune hepatitis-like serological manifestations.

    Published in:
    1999
    By:
    • Yoshikawa, Masahide;
    • Toyohara, Masahisa;
    • Yamane, Yoshiko;
    • Mimura, Mayumi;
    • Miyamoto, Yoji;
    • Ueda, Shigehiko;
    • Kawamoto, Hiroshi;
    • Fukui, Hiroshi;
    • Kobayashi, Tatsuro;
    • Hayashi, Eijiro;
    • Nakamura, Akira;
    • Yoshikawa, M;
    • Toyohara, M;
    • Yamane, Y;
    • Mimura, M;
    • Miyamoto, Y;
    • Ueda, S;
    • Kawamoto, H;
    • Fukui, H;
    • Kobayashi, T
    Publication type:
    journal article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50